Literature DB >> 17235526

C-peptide is a bioactive peptide.

J Wahren1, K Ekberg, H Jörnvall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17235526     DOI： 10.1007/s00125-006-0559-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  46 in total

1.  Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.

Authors:  G Zerbini; R Mangili; L Luzi
Journal:  Diabet Med       Date:  1999-12       Impact factor: 4.359

2.  Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells.

Authors:  N M Al-Rasheed; F Meakin; E L Royal; A J Lewington; J Brown; G B Willars; N J Brunskill
Journal:  Diabetologia       Date:  2004-05-26       Impact factor: 10.122

Review 3.  Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide.

Authors:  Anders A F Sima
Journal:  J Neurol Sci       Date:  2004-05-15       Impact factor: 3.181

4.  Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

Authors:  Y Ido; A Vindigni; K Chang; L Stramm; R Chance; W F Heath; R D DiMarchi; E Di Cera; J R Williamson
Journal:  Science       Date:  1997-07-25       Impact factor: 47.728

Review 5.  Mechanisms of endothelial dysfunction with development of type 1 diabetes mellitus: role of insulin and C-peptide.

Authors:  Irving G Joshua; Qin Zhang; Jeff C Falcone; Adrienne P Bratcher; Walter E Rodriguez; Suresh C Tyagi
Journal:  J Cell Biochem       Date:  2005-12-15       Impact factor: 4.429

6.  C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Authors:  Karin Ekberg; Tom Brismar; Bo-Lennart Johansson; Per Lindström; Lisa Juntti-Berggren; Anders Norrby; Christian Berne; Hans J Arnqvist; Jan Bolinder; John Wahren
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

7.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

8.  Effects of C-peptide on renal function at the early stage of experimental diabetes.

Authors:  M Sjöquist; W Huang; B L Johansson
Journal:  Kidney Int       Date:  1998-09       Impact factor: 10.612

9.  C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Authors:  Z Zhong; A Davidescu; I Ehrén; K Ekberg; H Jörnvall; J Wahren; A V Chibalin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

10.  Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration.

Authors:  Christopher R Pierson; Weixian Zhang; Anders A F Sima
Journal:  J Neuropathol Exp Neurol       Date:  2003-07       Impact factor: 3.685
View more
  38 in total

1.  Immune intervention in children with type 1 diabetes.

Authors:  Johnny Ludvigsson
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

2.  C-peptide: a redundant relative of insulin?

Authors:  L Luzi; G Zerbini; A Caumo
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

3.  How the immunoassay transformed C-peptide from a duckling into a swan.

Authors:  J Roth; I Whitford; R Dankner; A L Szulc
Journal:  Diabetologia       Date:  2012-01-13       Impact factor: 10.122

Review 4.  The role of immunomodulation therapy in autoimmune diabetes.

Authors:  Johnny Ludvigsson
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

5.  C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes.

Authors:  P Luppi; X Geng; V Cifarelli; P Drain; M Trucco
Journal:  Diabetologia       Date:  2009-08-07       Impact factor: 10.122

Review 6.  Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.

Authors:  Kwang-Chul Kwon; Dheeraj Verma; Nameirakpam D Singh; Roland Herzog; Henry Daniell
Journal:  Adv Drug Deliv Rev       Date:  2012-10-23       Impact factor: 15.470

7.  Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Authors:  E O Aarts; J Janssen; I M C Janssen; F J Berends; D Telting; H de Boer
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

8.  Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.

Authors:  J A Meyer; J M Froelich; G E Reid; W K A Karunarathne; D M Spence
Journal:  Diabetologia       Date:  2007-10-27       Impact factor: 10.122

Review 9.  Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.

Authors:  Piero Marchetti; Roberto Lupi; Silvia Del Guerra; Marco Bugliani; Valentina D'Aleo; Margherita Occhipinti; Ugo Boggi; Lorella Marselli; Matilde Masini
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

10.  Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.

Authors:  Sergio A Dib; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-04       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.